Department of Nuclear Medicine and Endocrine Oncology, TUTHYREF (Tumeurs de la Thyroïde Réfractaires) Network, Gustave Roussy and University Paris-Saclay, Villejuif, France.
Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy.
Endocr Relat Cancer. 2018 Apr;25(4):R209-R223. doi: 10.1530/ERC-17-0542. Epub 2018 Jan 25.
Distant metastases from thyroid cancer of follicular origin are uncommon. Treatment includes levothyroxine administration, focal treatment modalities with surgery, external radiation therapy and thermal ablation, and radioiodine in patients with uptake of I in their metastases. Two-thirds of distant metastases become refractory to radioiodine at some point, and when there is a significant tumor burden and documented progression on imaging, a treatment with a kinase inhibitor may provide benefits.
甲状腺滤泡细胞来源的癌远处转移并不常见。治疗包括左甲状腺素的应用、有摄取碘的转移灶时采用手术、外放射治疗和热消融等局部治疗手段,以及放射性碘治疗。三分之二的远处转移灶在某一时刻会对放射性碘产生抵抗,当肿瘤负荷较大且影像学上有明确进展时,激酶抑制剂治疗可能会带来获益。